Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

2020-03-24 10:05

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.

Go back

News

2022-12-06 13:24

Webinar

We are constantly improving our knowledge to assure the best possible quality of our services.

Medical Guide Where to Treat 2022

On 29^th of April, a special thematic supplement was published in the Polska The Times and Miasto.pl newspaper - Medical Guide Where to Treat 2022...

2022-03-01 10:45

BRG Support for Ukraine

We are deeply moved and concerned by the events in Ukraine. As a clinical site, focused on the development of medicine and helping other people,...

From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects.

2022-02-24 19:30

Completion of a single-center phase I study of the safety and pharmacokinetics of CPL207280

We have just completed a phase I study of safety and pharmacokinetics (part B) of an innovative therapy that could be used...

Page 6 of 14